PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Perphenazine And Amitriptyline Hydrochloride, and when can generic versions of Perphenazine And Amitriptyline Hydrochloride launch?
Perphenazine And Amitriptyline Hydrochloride is a drug marketed by Chartwell Rx, Fosun Pharma, Ivax Sub Teva Pharms, Mylan, Par Pharm, Sun Pharm Industries, and Watson Labs. and is included in thirty-five NDAs.
The generic ingredient in PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE is amitriptyline hydrochloride; perphenazine. There are thirteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the amitriptyline hydrochloride; perphenazine profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE?
- What are the global sales for PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE?
- What is Average Wholesale Price for PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE?
Summary for PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 7 |
| NDAs: | 35 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 5 |
| Clinical Trials: | 1 |
| Patent Applications: | 26 |
| DailyMed Link: | PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Hospital Civil de Guadalajara | Phase 2 |
| University of Guadalajara | Phase 2 |
| Institute of Experimental and Clinical Therapeutics | Phase 2 |
See all PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE clinical trials
Pharmacology for PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE
| Drug Class | Phenothiazine Tricyclic Antidepressant |
